2020 has been a year of change, including in high-stakes class action litigation. From the Eleventh Circuit shutting down incentive payments, to courts coming to grips with Bristol-Myers in the class context, the year has been filled with major developments. Notably, the courts have also begun to lay the groundwork for additional developments, setting up a 2021 that may be as tumultuous as this last year.